1-BUTYL-8-[4-[(4-BENZYLPIPERAZIN-1-YL)-2-OXOETHOXY]-PHENYL]-XANTHINE
Compound with spectra: 1 NMR
![1-BUTYL-8-[4-[(4-BENZYLPIPERAZIN-1-YL)-2-OXOETHOXY]-PHENYL]-XANTHINE](/api/compound/LFyUw8h2SXv.png?ph=true&h=300&w=458 "1-BUTYL-8-[4-[(4-BENZYLPIPERAZIN-1-YL)-2-OXOETHOXY]-PHENYL]-XANTHINE")
| SpectraBase Compound ID | LFyUw8h2SXv |
|---|---|
| InChI | InChI=1S/C28H32N6O4/c1-2-3-13-34-27(36)24-26(31-28(34)37)30-25(29-24)21-9-11-22(12-10-21)38-19-23(35)33-16-14-32(15-17-33)18-20-7-5-4-6-8-20/h4-12H,2-3,13-19H2,1H3,(H,29,30)(H,31,37) |
| InChIKey | AARZBDDJPFYPSG-UHFFFAOYSA-N |
| Mol Weight | 516.6 g/mol |
| Molecular Formula | C28H32N6O4 |
| Exact Mass | 516.248504 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
1-BUTYL-8-[4-[(4-ACETYLPIPERAZIN-1-YL)-2-OXOETHOXY]-PHENYL]-XANTHINE
1-BUTYL-8-[4-[(4-PHENYLPIPERAZIN-1-YL)-2-OXOETHOXY]-PHENYL]-XANTHINE
1-BUTYL-8-[4-[(4-ETHOXYCARBONYL-PIPERAZIN-1-YL)-2-OXOETHOXY]-PHENYL]-XANTHINE
1-BUTYL-8-[4-[(4-CARBOXYMETHYL)-PHENYLAMINO-2-OXOETHOXY]-PHENYL]-XANTHINE
3-(3,4-Dimethoxyphenyl)-6-methylpyrimido[5,4-E][1,2,4]triazine-5,7(6H,8H)-dione
5,6,7,8-TETRAHYDRO-3-(PARA-METHOXYPHENYL)-6,8-DIMETHYLPYRIMIDO[5,4-E][1,2,4]-TRIAZIN-5,7-DIONE
5,6,7,8-TETRAHYDRO-3-(PARA-NITROPHENYL)-6,8-DIMETHYLPYRIMIDO[5,4-E][1,2,4]-TRIAZIN-5,7-DIONE
3-[4-(dimethylamino)phenyl]-6,8-dimethylpyrimido[5,4-e][1,2,4]triazine-5,7(6H,8H)-dione
8-Butyl-9-(2-hydroxyethyl)-1-methyl-3H-purine-2,6-dione
8-{[4-(2-fluorophenyl)-1-piperazinyl]methyl}-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione
| Title | Journal or Book | Year |
|---|---|---|
| 1,8-Disubstituted Xanthine Derivatives: Synthesis of Potent A2B-Selective Adenosine Receptor Antagonists | Journal of Medicinal Chemistry | 2002 |